Keyphrases
Organic Osmolytes
65%
Cisplatin
63%
NIH3T3
49%
Mouse Embryonic Fibroblasts
49%
Cancer Cells
48%
Apoptosis
44%
Cell Volume
44%
Taurine Transport
43%
Cisplatin Resistance
40%
Taurine Release
36%
Anion Channel
34%
Swelling-induced
32%
Ehrlich Ascites Carcinoma
32%
Homeostasis
29%
Cell Volume Regulation
29%
Cisplatin-induced
28%
Induced Apoptosis
28%
Drug Resistance
27%
Non-adherent
27%
Hypo-osmotic
27%
Ehrlich Ascites
25%
Organic Anions
25%
Reactive Oxygen Species
24%
Regulatory Volume Decrease
24%
Cell Shrinkage
24%
Protein Kinase CK2
23%
Homologous Desensitization
23%
Cellular Accumulation
23%
P53 Expression
23%
Leucine-rich Repeat Containing 8A
23%
Cl Channel
23%
Carcinoma Cells
23%
Ascites
22%
LRRC8A
22%
Volume-regulated Anion Channel
22%
Hydrogen Peroxide
22%
VSOAC
21%
Efflux
21%
ANO1
20%
Cell Swelling
19%
A2780
19%
3T3 Fibroblasts
18%
Cellular Uptake
17%
Cell Behavior
17%
Mammalian Target of Rapamycin (mTOR)
17%
Ca2+
16%
Cell Size Homeostasis
16%
In Cancer
16%
Pt(II) Complexes
15%
K-Cl Cotransporter
15%
Biochemistry, Genetics and Molecular Biology
Taurine
100%
Fibroblast
79%
Cell Volume
69%
Programmed Cell Death
62%
Leucine-Rich Repeat
56%
Cisplatin
54%
Cell Swelling
44%
P53
39%
Downregulation
38%
Homeostasis
36%
Casein Kinase 2
35%
Phospholipase A2
33%
Potassium Channel
32%
Cancer Cell
31%
Drug Resistance
26%
Cell Function
24%
Homologous Desensitization
23%
Melittin
23%
Adipocyte
23%
ANO1
23%
calcium activated,phospholipid dependent protein kinase
23%
Caspase 3
22%
Serine
18%
Mechanistic Target of Rapamycin
17%
Messenger RNA
16%
Threonine
15%
Protein Expression
15%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
86%
Malignant Neoplasm
61%
Taurine
56%
Leucine
42%
Ehrlich Ascites Tumor
39%
Anion Channel
33%
Ascites
29%
Neoplasm
27%
Phospholipase A2
26%
Drug Resistance
25%
Arachidonate 5 Lipoxygenase
19%
Antiinfective Agent
17%
Calcium Ion
17%
Ovary Cancer
16%
Phospholipase A
15%
